# Efficacy and Safety of Transbronchial Bronchoscopic Thermal Vapor Ablation (BTVA) in Heterogeneous Emphysema

> **NCT06642038** · — · NOT_YET_RECRUITING · sponsor: **Ye Gu** · enrollment: 51 (estimated)

## Conditions studied

- Heterogeneous Emphysema

## Interventions

- **PROCEDURE:** Transbronchial Endoscopic Thermal Vapor Ablation

## Key facts

- **NCT ID:** NCT06642038
- **Lead sponsor:** Ye Gu
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-13
- **Primary completion:** 2025-09-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2024-10-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06642038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06642038, "Efficacy and Safety of Transbronchial Bronchoscopic Thermal Vapor Ablation (BTVA) in Heterogeneous Emphysema". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06642038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*